Maintenance or Consolidation Therapy in Advanced Ovarian Cancer

Publisher： Karger

E-ISSN： 1423-0232|70|5|315-324

ISSN： 0030-2414

Source： Oncology, Vol.70, Iss.5, 2007-01, pp. : 315-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improved Survival with Single-Agent Paclitaxel Consolidation/Maintenance Therapy in Advanced Ovarian Carcinoma

By  

Oncology, Vol. 71, Iss. 1-2, 2007-04 ,pp. : 49-53

Karger

Access to resources Recommend Favorite

The Promise and Perils of ‘Targeted Therapy’ of Advanced Ovarian Cancer

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Successful Treatment of Advanced Ovarian Cancer with Thermochemotherapy and Adjuvant Immune Therapy

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-05 ,pp. : 212-215

Karger

Access to resources Recommend Favorite

Patients with Advanced Ovarian Cancer Administered Oral Etoposide following Taxane as Maintenance Chemotherapy

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-03 ,pp. : 195-204

Karger

Access to resources Recommend Favorite

Personalizing therapy for ovarian cancer

By Tran Chau   McNally Thomas   Birrer Michael J  

Therapy, Vol. 7, Iss. 3, 2010-05 ,pp. : 229-239

Future Medicine

Access to resources Recommend Favorite